Circulating Cell Free DNA (ccfDNA)
<p>Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients</p>
... Circulating cell-free DNA appears following cell damage, and its levels are increased in pathological con- ditions characterized by marked in fl ammation such as cancer, severe sepsis, ...
9
Prognostic and diagnostic value of eosinopenia, C reactive protein, procalcitonin, and circulating cell free DNA in critically ill patients admitted with suspicion of sepsis
... of circulating cell-free DNA (cf-DNA) concentrations, compared with C-reactive protein (CRP), procalcitonin (PCT) and eosinophil count, in the diagnosis of infections in patients with ...
9
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
... with circulating cell-free DNA (cf-DNA) and circulating tumor cells (CTCs) emerging as “ liquid biopsies ” ...of circulating tumor DNA (ct-DNA) and CTCs ...
10
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
... Circulating cell-free DNA (cfDNA), which can be obtained from plasma or serum by non-invasive procedures, has showed great potential to predict treatment response and survival for cancer ...
13
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
... “cell free DNA OR circulating DNA OR circulating tumor DNA OR serum DNA OR plasma DNA” AND “lung cancer OR non-small cell lung cancer” AND “EGFR OR ...
12
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.
... Prostate cancer is a major cause of male cancer mortality globally. Studies indicate substantial inter- and intra-patient genomic heterogeneity although treatment to date has not incorporated molecular stratification. ...
34
Cancer gene mutation detection in circulating cell free DNA in blood
... (short DNA oligonucleotides complementary to a specific target DNA sequence) but they additionally have a fluorescent “reporter” dye molecule bound to the ...synthesised DNA molecule (during PCR) the ...
296
Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
... plasma DNA as a “liquid biopsy” has rarely been applied to hepatocellular carcinoma (HCC), even though it is the fifth most common cause of cancer in the world [11] and the mortality rate is rapidly ...
10
<p>Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer</p>
... Researches centered on other genetic alterations or gene panels with several selected genes of cfDNA/ctDNA were also carried out. Cohen et al conducted a proof-of-concept study for subchromosomal with a low coverage ...
14
Emerging molecular technologies in renal cell carcinoma: liquid biopsy
... the circulating tumor cells (CTCs) and cell-free nucleic acids ...(i.e., circulating cell-free DNA (ccfDNA), circulating tumor DNA (ctDNA), ...
18
Liquid Biopsy in Liquid Tumors
... need. Circulating cell free DNA (ccfDNA), other cir- culating nucleic acids such as microRNA and circulating tumor cells (CTCs), can be obtained from a peripheral blood ...of ...
20
Cell Free DNA and CD38 Expression on T helper Cells as Biomarkers of Disease Activity in Rheumatoid Arthritis
... life. Circulating cell-free DNA (cfDNA) is a cell damage marker, while CD38 molecule expressed on immune cells is involved in activation, and survival ...
9
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics.
... circulating cell free DNA evaluating tumor clone response to molecularly targeted drug. 497 [r] ...
41
Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients
... clear cell carcinoma (OCCCs) ...samples, circulating cell-free DNA (cf-DNA) and circulating tumor cells (CTCs) [23] have emerged as “liquid biopsies” for non-invasive ...
10
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
... In other studies, the predictive value of response in the first staging was significant for melanoma patients with either no detection of ctDNA baseline or with posi- tive baseline ctDNA becoming undetectable within 12 ...
15
Detection of short tandem repeats at 5 loci and amelogenin with cell-free fetal DNA as a specimen in the development of prenatal paternity diagnostic tests
... of DNA amplification. In forensic science, particularly the field of DNA typing, this method is also applied due to its ability to amplify small quantities of DNA (Kashyap et ...target DNA in ...
5
Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study
... creatic cell lines [6, 7, 18, ...insulin-coding cell-free DNA (INScfDNA) compared with healthy con- trols [20], there is no knowledge of whether an increased amount of unmethylated ...
10
Changes in circulating cell free nuclear DNA and mitochondrial DNA of patients with adolescent idiopathic scoliosis
... mt- DNA are associated with differential metabolic profiles and conditions characterized by chronic inflammation or oxidative stress that are involved in the pathogenesis of muscle wasting disorders [26, ...
11
Detection of kras mutation in circulating free dna (cfdna)
... mutant DNA represents only a small fraction of total cfDNA (Diehl et ...cancer cell clones (which account for the genomic and epigenomic heterogeneity of tumours) and other normal cell types, such as ...
8
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
... plasma cell-free DNA Twenty milliliters (mLs) of peripheral whole blood were collected in K3 EDTA tubes for frozen samples (cohort A) or in K3 EDTA-containing Streck tubes (Cell-Free ...
13